Snapshot from Aug 13, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / TriNetX appoints August Calhoun CEO
Business CEO appointment

TriNetX appoints August Calhoun CEO

Analysis based on 9 articles · First reported Jul 27, 2026 · Last updated Jul 27, 2026

Sentiment
10
Attention
1
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The CEO transition signals stability and continued growth for TriNetX, a private company. The appointment of an experienced healthcare data leader may enhance its competitive position in real-world evidence generation.

Healthcare Data Analytics
Event Summary

TriNetX, operator of a global federated health data network, announced the appointment of August Calhoun as CEO, effective July 27, 2026. Jeff Margolis, who served as Interim CEO and Executive Chairman since December 2024, resumes his role as Chairman. Calhoun brings over 25 years of experience from RLDatix, Insight Partners, GE HealthCare, and Siemens. The company also highlighted recent achievements under Margolis: a strategic collaboration with Regeneron, acquisition of Zetta Genomics, and network growth to over 300 million patients across 25 countries. TriNetX is backed by The Carlyle Group.

Key Actions
80 TriNetX appointed CEO August Calhoun
75 TriNetX grew network beyond
70 TriNetX collaborated with Regeneron Pharmaceuticals
65 TriNetX acquired assets of Zetta Genomics
60 Jeff Margolis resumed chairman role
Entities Involved
priv
TriNetX
TriNetX appointed a new CEO and completed a leadership transition, positioning for growth.
Importance 100.0 Sentiment 10.0
per
August Calhoun
August Calhoun was appointed CEO of TriNetX, bringing extensive healthcare data experience.
Importance 80.0 Sentiment 10.0
per
Jeff Margolis
Jeff Margolis resumed Chairman role after serving as Interim CEO, overseeing key achievements.
Importance 60.0 Sentiment 5.0
stock
The Carlyle Group
Carlyle is TriNetX's lead investor; partner Joe Bress commented on the transition.
Importance 40.0 Sentiment 5.0
stock
Regeneron Pharmaceuticals
Regeneron has a strategic collaboration and investment with TriNetX.
Importance 30.0 Sentiment 5.0
per
Joe Bress
Joe Bress, Carlyle partner, welcomed the new CEO and thanked Margolis.
Importance 20.0 Sentiment 0.0
priv
Zetta Genomics
TriNetX acquired assets of Zetta Genomics during Margolis's interim tenure.
Importance 20.0 Sentiment 5.0
stock
Siemens
Siemens is a former employer of August Calhoun.
Importance 10.0 Sentiment 0.0
priv
RLDatix
RLDatix is a former employer of August Calhoun.
Importance 10.0 Sentiment 0.0
priv
Insight Partners
Insight Partners is a former employer of August Calhoun.
Importance 10.0 Sentiment 0.0
stock
GE HealthCare
GE HealthCare is a former employer of August Calhoun.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.